VitaBerry (Fruit blend)

VitaBerry is a proprietary fruit blend standardized to deliver concentrated polyphenols — including anthocyanins, resveratrol, and ellagic acid — with a reported 6,000 ORAC units per gram. These compounds primarily act as free radical scavengers and may modulate NF-κB signaling pathways to support antioxidant defense and reduce oxidative stress markers.

Origin & History

VitaBerry is a proprietary branded blend of fruit powders and extracts developed by FutureCeuticals, combining ingredients such as wild blueberry, raspberry, prune, cranberry, tart cherry, strawberry, wild bilberry, grape, bilberry extract, grape seed extract, and blueberry extract. It is processed via freeze-drying, dehydration, and proprietary extraction techniques to preserve polyphenols without solvents or high heat, standardized to contain at least 30% polyphenols and delivering 6,000 ORAC units per gram.

Historical & Cultural Context

No historical or traditional medicine context exists for VitaBerry as it is a modern proprietary blend without ties to specific traditional systems. While individual component berries like bilberry and blueberry have general use in food and folk remedies, these uses are not specifically linked to the VitaBerry formulation.

Health Benefits

• High antioxidant capacity with 6,000 ORAC units per gram (proprietary data, no clinical trials)
• Potential oxidative stress reduction through polyphenolic compounds including anthocyanins and resveratrol (preliminary animal evidence only)
• May support cellular inflammation reduction via polyphenol-mediated pathways (theoretical based on component studies)
• Possible nitric oxide inhibition from blackberry anthocyanin components (in-vitro component data only)
• Concentrated source of diverse fruit polyphenols including ellagic acid, chlorogenic acid, and proanthocyanidins (no human studies available)

How It Works

VitaBerry's anthocyanins donate electrons to neutralize reactive oxygen species (ROS) and upregulate endogenous antioxidant enzymes including superoxide dismutase (SOD) and glutathione peroxidase. Resveratrol activates SIRT1 deacetylase and inhibits NF-κB transcription factor activity, potentially dampening pro-inflammatory cytokine expression such as IL-6 and TNF-α. Ellagic acid undergoes gut microbiome conversion to urolithin A, which may further support mitochondrial autophagy and cellular redox balance.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted specifically on VitaBerry according to available research. The evidence base consists primarily of animal studies indicating potential antioxidant effects and component analyses focusing on extraction methods and polyphenol content rather than clinical outcomes.

Clinical Summary

Evidence for VitaBerry specifically is limited to proprietary in vitro assays and preliminary animal studies; no published randomized controlled trials using the branded blend have been identified as of early 2025. Individual component studies — such as those on blueberry anthocyanins — have shown reductions in oxidative stress biomarkers (e.g., 8-isoprostane, MDA) in small human trials ranging from 20 to 60 participants over 4 to 12 weeks. Resveratrol research in humans has produced mixed results, with bioavailability remaining a significant limitation without phospholipid or nanoparticle delivery systems. Overall, the evidence base is preliminary and extrapolation from single-ingredient studies to this multi-fruit blend should be done cautiously.

Nutritional Profile

VitaBerry (Fruit blend) is a proprietary concentrated fruit blend typically composed of wild blueberry, raspberry, strawberry, cranberry, prune, cherry, and grape. Macronutrient content per typical serving (5–10g powder): carbohydrates 3–7g (primarily simple sugars and dietary fiber 0.5–1.5g), protein <0.5g, fat <0.2g. Caloric density approximately 15–35 kcal per serving. Micronutrients present at moderate levels include Vitamin C (approximately 10–30mg per serving depending on processing), Vitamin K (2–8mcg), manganese (0.1–0.3mg), and trace amounts of potassium, magnesium, and folate; exact concentrations vary by lot and processing method. Bioactive compounds are the primary nutritional distinction: anthocyanins (cyanidin, delphinidin, malvidin glycosides; estimated 50–150mg per serving), proanthocyanidins (20–80mg), resveratrol (low concentration, typically <1mg), ellagic acid, quercetin, chlorogenic acid, and pterostilbene. Total polyphenol content estimated at 200–500mg per serving. Bioavailability notes: anthocyanin absorption is relatively low (typically 1–5% systemic bioavailability), heavily influenced by gut microbiota metabolism; resveratrol undergoes rapid first-pass metabolism limiting systemic exposure; polyphenol bioavailability is enhanced in whole-food matrix versus isolated compounds; freeze-drying or spray-drying processing methods may reduce thermolabile constituents such as Vitamin C by 10–30%. Fiber content supports prebiotic activity relevant to polyphenol colonic conversion.

Preparation & Dosage

No clinically studied dosage ranges are available for VitaBerry as human trials have not been conducted. Commercial products reference 6,000 ORAC units per 1 gram of VitaBerry High ORAC powder, standardized to at least 30% polyphenols, but this is not tied to clinical dosing recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Vitamin E, Green Tea Extract, Resveratrol, Alpha-Lipoic Acid

Safety & Interactions

VitaBerry is generally considered well-tolerated at typical supplement doses (500–1,000 mg/day), with mild gastrointestinal upset being the most commonly reported side effect in sensitive individuals. Resveratrol within the blend may weakly inhibit CYP3A4 and CYP2C9 enzymes, creating a theoretical interaction risk with anticoagulants like warfarin and immunosuppressants like cyclosporine — patients on these medications should consult a physician. Anthocyanin-rich blends may potentiate the effect of antiplatelet drugs such as aspirin or clopidogrel, increasing bleeding risk at high doses. Safety data during pregnancy and lactation is insufficient; use is not recommended without medical supervision.